Author:
Bauer Kenneth S.,Petros William P.
Reference22 articles.
1. Figg WD, Stevens JA, Cooper MR. Adaptive control with feedback of suramin using intermittent infusions. J Clin Oncol 1994; 12: 1523–1524.
2. Lowis SP, Price L, Pearson AD, Newell DR, Cole M. A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children. Br J Cancer 1998; 77: 2318–2323.
3. Ghazal-Aswad S, Tilby MJ, Lind M, et al. Pharmacokinetically guided dose escalation of carboplatin in epithelial ovarian cancer: effect on drug-plasma AUC and peripheral blood drug-DNA adduct levels. Ann Oncol 1999; 10: 329–334.
4. Bauer KS, Figg WD, Hamilton JM, et al. A pharmacokinetically guided Phase II study of carboxyamidotriazole in androgen-independent prostate cancer. Clin Cancer Res 1999; 5: 2324–2329.
5. Ratain MJ, Mick R, Janisch L, et al. Individualized dosing of amonafide based on a pharmacodynamic model incorporating acetylator phenotype and gender. Pharmacogenetics 1996; 6: 93–101.